2-((-1-benzyl-indazol-3-yl)methoxy)-2-methylpropionic acid,
2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropionic acid,
2-((1-benzyl-3-indazolyl)methoxy)-2-methylpropionic acid,
bindarit,
Bindarit,
130641-38-2,
2-((1-Benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid,
UNII-JQ11LH711M,
AF2838,
AF 2838,
JQ11LH711M,
2-[(1-benzyl-1h-indazol-3-yl)methoxy]-2-methylpropanoic acid,
AF-2838,
Propanoic acid, 2-methyl-2-[[1-(phenylmethyl)-1H-indazol-3-yl]methoxy]-,
2-[(1-benzylindazol-3-yl)methoxy]-2-methylpropanoic acid,
SMR004701447,
Bindarit [USAN:INN],
Propanoic acid, 2-methyl-2-((1-(phenylmethyl)-1H-indazol-3-yl)methoxy)-,
ACMC-20agak,
Bindarit (USAN/INN),
AC1Q5SW4,
MLS006010421,
MLS006011107,
SCHEMBL187885,
AC1L2G05,
ZINC4594,
CHEMBL2107549,
CTK4B6848,
DTXSID30156660,
MTHORRSSURHQPZ-UHFFFAOYSA-N,
HMS3656P16,
KUC114730N,
2-((1-Benzyl-1H-indazol-3-yl)methoxy)-2-methylpropionic acid,
BCP22728,
HY-B0498,
KS-00001F7J,
ANW-72042,
s3032,
AKOS016007434,
BCP9000414,
CS-2620,
DB12739,
SB16551,
TRA0056340,
NCGC00346710-01,
NCGC00346710-03,
4CA-0279,
AJ-08221,
KSC-441-99-2,
AB0032735,
AX8116716,
TX-011598,
B2156,
FT-0700588,
ST24038935,
SW219174-1,
X6136,
A11821,
D03116,
AB01566103_02,
A1-01899,
2-(1-Benzyl-1H-indazol-3-yl)methoxy-2-methylpropanoic acid,
2-(1-Benzyl-1H-indazol-3-ylmethoxy)-2-methyl-propionic acid,
2-[(1-Benzyl-1H-indazol-3-yl)methoxy]-2-methylpropanoicacid;,
2-methyl-2-[(1-benzyl-1H-indazol-3-yl)methoxy]propanoic acid,
2-[1(1-benzyl-1H-indazol-3-yl)methoxy]-2-methylpropanoic acid,
Propanoic acid,2-methyl-2-[[1-(phenylmethyl)-1H-indazol-3-yl]methoxy]-,
D0XM4G,
Bindarit, Angelini Pharmaceuticals,
C19H20N2O3,
CID71354,
AR-1D5384,
C19-H20-N2-O3,
CCL2 inhibitor (inflammatory disorders/kidney disease), Angelini Pharmaceuticals,
MCP-1 inhibitor (inflammatory disorder/kidney disease), Angelini Pharmaceuticals,
13153-29-2,